Progress in 3D Bioprinting Technology for Osteochondral Regeneration

The aging of the population, coupled with the rising prevalence of risk factors such as obesity, physical inactivity, and excessive exercise, has brought osteoarticular diseases to the forefront of medical attention. Osteochondral defects are defined by the disruption of cartilage accompanied by damage to the underlying bone. Furthermore, injuries to osteochondral tissue can contribute to the development of osteoarthritis (OA). As cartilage loses its structural integrity, it becomes more susceptible to damage from physical forces. OA, a progressive and degenerative joint ailment, currently lacks a definitive cure. In the early stages of OA, treatment primarily focuses on patient education, weight management, and controlled physical activity. As the condition advances, the primary goal shifts to mitigating its most debilitating symptom: chronic pain.
In this context, tissue engineering has emerged as the most promising therapeutic approach, bringing together elements of cell therapy, biomaterial engineering, and the targeted delivery of drugs or therapeutic molecules. Central to this approach is the creation of three-dimensional (3D) structures or scaffolds that provide essential support to cells, enabling their adhesion, proliferation, and differentiation. These structures can also incorporate various elements, including drugs, growth factors, and therapeutic molecules. Among the various techniques for scaffold fabrication, 3D bioprinting has gained significant prominence in recent years. This additive manufacturing method involves the layer-by-layer construction of structures guided by computer-aided design, promising new avenues for enhanced treatment options. For more detailed information, please refer to the provided link.